180 related articles for article (PubMed ID: 8605955)
1. Peptoid CCK receptor antagonists: pharmacological evaluation of CCKA, CCKB and mixed CCKA/B receptor antagonists.
Singh L; Field MJ; Hill DR; Horwell DC; McKnight AT; Roberts E; Tang KW; Woodruff GN
Eur J Pharmacol; 1995 Nov; 286(2):185-91. PubMed ID: 8605955
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and "mixed" CCK-A/CCK-B antagonists.
Boden PR; Higginbottom M; Hill DR; Horwell DC; Hughes J; Rees DC; Roberts E; Singh L; Suman-Chauhan N; Woodruff GN
J Med Chem; 1993 Mar; 36(5):552-65. PubMed ID: 7684452
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vitro.
Taniguchi H; Yazaki N; Endo T; Nagasaki M
Eur J Pharmacol; 1996 May; 304(1-3):147-54. PubMed ID: 8813597
[TBL] [Abstract][Full Text] [Related]
4. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.
Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
Br J Pharmacol; 1995 Jan; 114(2):339-48. PubMed ID: 7881733
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models.
Ballaz S; Barber A; Fortuño A; Del Río J; Martin-Martínez M; Gómez-Monterrey I; Herranz R; González-Muñiz R; García-López MT
Br J Pharmacol; 1997 Jun; 121(4):759-67. PubMed ID: 9208145
[TBL] [Abstract][Full Text] [Related]
6. The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze.
Bickerdike MJ; Marsden CA; Dourish CT; Fletcher A
Eur J Pharmacol; 1994 Dec; 271(2-3):403-11. PubMed ID: 7705440
[TBL] [Abstract][Full Text] [Related]
7. Cytosolic Ca2+ evaluation in rabbit parietal cells: a novel method to screen gastrin receptor antagonists.
Letari O; Mennuni L; Revel L; Colombo S; Makovec F
Eur J Pharmacol; 1996 Jun; 306(1-3):325-33. PubMed ID: 8813647
[TBL] [Abstract][Full Text] [Related]
8. Rationally designed "dipeptoid" analogues of CCK. alpha-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties.
Horwell DC; Hughes J; Hunter JC; Pritchard MC; Richardson RS; Roberts E; Woodruff GN
J Med Chem; 1991 Jan; 34(1):404-14. PubMed ID: 1671419
[TBL] [Abstract][Full Text] [Related]
9. Second generation "peptoid" CCK-B receptor antagonists: identification and development of N-(adamantyloxycarbonyl)-alpha-methyl-(R)-tryptophan derivative (CI-1015) with an improved pharmacokinetic profile.
Trivedi BK; Padia JK; Holmes A; Rose S; Wright DS; Hinton JP; Pritchard MC; Eden JM; Kneen C; Webdale L; Suman-Chauhan N; Boden P; Singh L; Field MJ; Hill D
J Med Chem; 1998 Jan; 41(1):38-45. PubMed ID: 9438020
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists.
Bertrand P; Böhme GA; Durieux C; Guyon C; Capet M; Jeantaud B; Boudeau P; Ducos B; Pendley CE; Martin GE
Eur J Pharmacol; 1994 Sep; 262(3):233-45. PubMed ID: 7813588
[TBL] [Abstract][Full Text] [Related]
11. CR 2945: a novel CCKB receptor antagonist with anxiolytic-like activity.
Revel L; Mennuni L; Garofalo P; Makovec F
Behav Pharmacol; 1998 May; 9(3):183-94. PubMed ID: 9832933
[TBL] [Abstract][Full Text] [Related]
12. Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosa.
Heinemann A; Jocic M; Holzer-Petsche U; Pethö G; Peskar BM; Horwell DC; Holzer P
Br J Pharmacol; 1995 Oct; 116(4):2274-8. PubMed ID: 8564259
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the in vivo actions of morphine by the mixed CCKA/B receptor antagonist PD 142898.
Singh L; Field MJ; Hunter JC; Oles RJ; Woodruff GN
Eur J Pharmacol; 1996 Jul; 307(3):283-9. PubMed ID: 8836616
[TBL] [Abstract][Full Text] [Related]
14. Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors.
Gully D; Fréhel D; Marcy C; Spinazzé A; Lespy L; Neliat G; Maffrand JP; Le Fur G
Eur J Pharmacol; 1993 Feb; 232(1):13-9. PubMed ID: 7681406
[TBL] [Abstract][Full Text] [Related]
15. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
Makovec F; Revel L; Letari O; Mennuni L; Impicciatore M
Eur J Pharmacol; 1999 Mar; 369(1):81-90. PubMed ID: 10204685
[TBL] [Abstract][Full Text] [Related]
16. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve.
Corp ES; McQuade J; Moran TH; Smith GP
Brain Res; 1993 Sep; 623(1):161-6. PubMed ID: 8221086
[TBL] [Abstract][Full Text] [Related]
17. Rationally designed "dipeptoid" analogues of CCK. Acid mimics of the potent and selective non-peptide CCK-B receptor antagonist CI-988.
Drysdale MJ; Pritchard MC; Horwell DC
J Med Chem; 1992 Jul; 35(14):2573-81. PubMed ID: 1635058
[TBL] [Abstract][Full Text] [Related]
18. Characterization of YM022: its CCKB/gastrin receptor binding profile and antagonism to CCK-8-induced Ca2+ mobilization.
Saita Y; Yazawa H; Honma Y; Nishida A; Miyata K; Honda K
Eur J Pharmacol; 1994 Oct; 269(2):249-54. PubMed ID: 7851501
[TBL] [Abstract][Full Text] [Related]
19. Several roles of CCKA and CCKB receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning.
Mosher JT; Johnson MF; Birkemo LS; Ervin GN
Peptides; 1996; 17(3):483-8. PubMed ID: 8735976
[TBL] [Abstract][Full Text] [Related]
20. Weak tolerance to the antinociceptive effect induced by the association of a peptidase inhibitor and a CCKB receptor antagonist.
Valverde O; Blommaert AG; Fournié-Zaluski MC; Roques BP; Maldonado R
Eur J Pharmacol; 1995 Nov; 286(1):79-93. PubMed ID: 8566154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
